key: cord-0941222-rpg3q6rt authors: Mohammadi, A.; Esmaeilzadeh, E.; Li, Y.; Bosch, R. J.; Li, J. title: SARS-CoV-2 Detection in Different Respiratory Sites: A Systematic Review and Meta-Analysis date: 2020-05-19 journal: medRxiv : the preprint server for health sciences DOI: 10.1101/2020.05.14.20102038 sha: 4e499340a0b791c74ae5ab722cb2beb57fa1d587 doc_id: 941222 cord_uid: rpg3q6rt Background: The accurate detection of SARS-CoV-2 through respiratory sampling is critical for the prevention of further transmission and the timely initiation of treatment for COVID-19. There is a diverse range of SARS-CoV-2 detection rates in reported studies, with uncertainty as to the optimal sampling strategy for COVID-19 diagnosis and monitoring. Methods: We performed a systematic review and meta-analysis of studies comparing respiratory sampling strategies for the detection of SARS-CoV-2 RNA. The inclusion criteria were studies that assessed at least two respiratory sampling sites (oropharyngeal swab, nasopharyngeal swab, and sputum) in participants with COVID-19. The percentage positive tests were compared between sampling modalities by constructing a Z-test assuming independence and using the standard errors obtained from the random effects meta-analysis. Findings: From 1039 total studies, we identified 11 studies that met our inclusion criteria, with SARS-CoV-2 testing results from a total of 3442 respiratory tract specimens. Compared to nasopharyngeal swab sampling, sputum testing resulted in significantly higher rates of SARS-CoV-2 RNA detection while oropharyngeal swab testing had lower rates of viral RNA detection. Earlier sampling after symptom onset was associated with improved detection rates, but the differences in SARS-CoV-2 RNA detection by sampling method was consistent regardless of the duration of symptoms. Interpretation: The results support sputum sampling as a primary method of COVID-19 diagnosis and monitoring, and highlight the importance of early testing after symptom onset to increase the rates of COVID-19 diagnosis. Worldwide, there are now over 3 million confirmed cases and 250,000 deaths due to detection rates with each of the diagnostic methods. In COVID-19 diagnosed 72 individuals, the reported SARS-CoV-2 detection rate has ranged from 25% to >70% of 73 collected nasopharyngeal swabs, 5,6 32% to 65% for oropharyngeal swabs, 2,5 and 48% 74 to >90% for sputum. 7, 8 This has led to significant uncertainty and confusion in the field 75 as to the reason behind the disparate testing results and the optimal diagnostic 76 sampling strategy for diagnosis and monitoring of COVID-19 patients. In this study, we (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint Search strategy and selection criteria 87 In this systematic review and meta-analysis, we used the Preferred Reporting Items for 88 Systematic Reviews and Meta-Analyses (PRISMA) to review literatures and report our 89 results ( Figure 1) . A computerized search was implemented in PubMed, MedRxiv and 90 BioRxiv using a search term, "((COVID OR COVID-19 OR SARS) AND (throat OR nasal 91 OR nasopharyngeal OR oropharyngeal OR oral OR saliva OR sputum OR PCR))". The The estimated percentages of positive SARS-CoV-2 qPCR tests and the 95% 106 confidence intervals were calculated for each sampling strategy using random-effects 107 meta-analyses for binomial data using Stata Metaprop package. 9 We also performed an 108 analysis stratified by the duration of symptoms prior to the testing, with results 109 categorized as 0-7 days, 8-14 days, >14 days from symptom onset. We compared the 110 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint proportion of positive tests between sampling sites by constructing a Z-test assuming 111 independence and using the standard errors obtained from the random effects meta- We used inconsistency index (I 2 ) test to assess the heterogeneity between each study. The funding source of this study had no role in study design, data extraction, data 124 analysis, data interpretation, or writing of this study. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint From the 1039 studies identified in our search, we excluded 21 duplicates and after (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint In the overall pooled analysis, we detected significant heterogeneity between studies (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint In this systematic review and meta-analysis, we combined data from 11 papers that in 161 total reported SARS-CoV-2 RNA testing from a total of 1299 nasopharyngeal swabs, (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . of the world, but their use has a number of drawbacks. First, nasopharyngeal swabs can 186 be technically challenging to obtain 4 and poor sample quality remains a problem. Thus, for those who are unable to produce sputum, nasopharyngeal testing may 208 continue to play an important role in the diagnosis or monitoring of COVID-19 patients. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint A recent report also suggested that saliva samples had comparable diagnostic accuracy 210 compared to nasopharyngeal swabs, although this will need to be confirmed with 211 additional studies. 23 Finally, there were differences between studies in the qPCR assay (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . RB, and JL were involved in the statistical analysis. All authors contributed to the writing 228 and editing of the manuscript. Acknowledgements 231 We would like to thank Dr. Myoung-don Oh for providing additional data from his 232 manuscript and the authors of contributing studies and MedRxiv for making the findings 233 available through publicly accessible pre-prints. 234 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Studies included in quantitative synthesis (meta-analysis) (n = 11) All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 19, 2020. . https://doi.org/10.1101/2020.05.14.20102038 doi: medRxiv preprint Figure 2 . Rates of SARS-CoV-2 detection by three methods of sampling. Forest plots of detection rates for oropharyngeal swabs (A), nasopharyngeal swabs (B), and sputum (C) and in a pooled analysis (D). The error bars in figure 2 D are 95% Confidence Interval (95% CI). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. A familial cluster of pneumonia associated with 236 the 2019 novel coronavirus indicating person-to-person transmission: a study of a family 237 cluster Detection of SARS-CoV-2 in Different Types of 239 Clinical Specimens Temporal profiles of viral load in posterior 241 oropharyngeal saliva samples and serum antibody responses during infection by SARS-242 CoV-2: an observational cohort study How to Obtain a Nasopharyngeal Swab Specimen Quantitative Detection and Viral Load Analysis of 246 SARS-CoV-2 in Infected Patients Clinical Course and Outcomes of Patients with 248 Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of 249 the First 28 Patients from the Korean Cohort Study on COVID-19 Detection and analysis of nucleic acid in various biological 252 samples of COVID-19 patients Improved Molecular Diagnosis of COVID-19 by 13 SARS-CoV-2-Positive Sputum and Feces After 267 Conversion of Pharyngeal Samples in Patients With COVID-19 Evaluation of SARS-CoV-2 RNA shedding in 269 clinical specimens and clinical characteristics of 10 patients with COVID-19 Viral load of SARS-CoV-2 in 272 clinical samples The clinical pathology of severe acute respiratory 274 syndrome (SARS): a report from China Post-mortem examination of